F.H. Schr�der

1.2k total citations
19 papers, 858 citations indexed

About

F.H. Schr�der is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, F.H. Schr�der has authored 19 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 4 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in F.H. Schr�der's work include Prostate Cancer Treatment and Research (14 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Urinary Bladder and Prostate Research (3 papers). F.H. Schr�der is often cited by papers focused on Prostate Cancer Treatment and Research (14 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Urinary Bladder and Prostate Research (3 papers). F.H. Schr�der collaborates with scholars based in Netherlands, United States and Sweden. F.H. Schr�der's co-authors include Wim J. Kirkels, Monique J. Roobol, Mark F. Wildhagen, René Raaijmakers, Johannes C. Romijn, Ries Kranse, Koen Ackaert, Theodorus van der Kwast, Harry J. de Koning and Petra M. M. Beemsterboer and has published in prestigious journals such as Cancer, International Journal of Cancer and Urology.

In The Last Decade

F.H. Schr�der

19 papers receiving 811 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F.H. Schr�der Netherlands 16 673 186 183 181 123 19 858
Gustavo de la Roza United States 15 705 1.0× 283 1.5× 232 1.3× 249 1.4× 261 2.1× 39 1.1k
H.Ballentine Carter United States 10 618 0.9× 108 0.6× 135 0.7× 167 0.9× 61 0.5× 12 767
Michael Froehner Germany 18 520 0.8× 172 0.9× 348 1.9× 178 1.0× 255 2.1× 66 1.0k
Oliver W. Hakenberg Germany 14 508 0.8× 136 0.7× 197 1.1× 55 0.3× 190 1.5× 57 724
Sven Wenske United States 21 684 1.0× 172 0.9× 283 1.5× 185 1.0× 188 1.5× 41 1.2k
S Conquy France 11 552 0.8× 67 0.4× 233 1.3× 204 1.1× 274 2.2× 48 802
Abdel-Rahmène Azzouzi France 14 438 0.7× 122 0.7× 297 1.6× 75 0.4× 282 2.3× 33 846
Vito Mancini Italy 18 294 0.4× 140 0.8× 240 1.3× 200 1.1× 173 1.4× 64 805
J. Erik Busby United States 16 350 0.5× 120 0.6× 582 3.2× 211 1.2× 207 1.7× 27 1.1k
Noriaki Utsunomiya Japan 14 288 0.4× 108 0.6× 382 2.1× 67 0.4× 167 1.4× 48 791

Countries citing papers authored by F.H. Schr�der

Since Specialization
Citations

This map shows the geographic impact of F.H. Schr�der's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.H. Schr�der with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.H. Schr�der more than expected).

Fields of papers citing papers by F.H. Schr�der

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.H. Schr�der. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.H. Schr�der. The network helps show where F.H. Schr�der may publish in the future.

Co-authorship network of co-authors of F.H. Schr�der

This figure shows the co-authorship network connecting the top 25 collaborators of F.H. Schr�der. A scholar is included among the top collaborators of F.H. Schr�der based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.H. Schr�der. F.H. Schr�der is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Raaijmakers, René, Wim J. Kirkels, Monique J. Roobol, Mark F. Wildhagen, & F.H. Schr�der. (2002). Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology. 60(5). 826–830. 299 indexed citations
2.
Madalinska, Joanna B., Marie‐Louise Essink‐Bot, Harry J. de Koning, et al.. (2001). Health-related quality of life in patients with screen-detected versus clinically diagnosed prostate cancer preceding primary treatment. The Prostate. 46(2). 87–97. 34 indexed citations
3.
Hoedemaeker, Robert F., et al.. (2001). The predictive value for prostate cancer of lesions that raise suspicion of concomitant carcinoma. Cancer. 92(3). 524–534. 25 indexed citations
4.
Jongsma, Johan, Marinus A. Noordzij, Johannes C. Romijn, et al.. (2000). Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines. The Prostate. 42(1). 34–44. 90 indexed citations
5.
Schr�der, F.H.. (2000). Endocrine treatment of prostate cancer. The Prostate. 45(S10). 1–1. 15 indexed citations
6.
Schr�der, F.H., et al.. (2000). Screening and early detection of prostate cancer. The Prostate. 44(3). 255–263. 25 indexed citations
7.
Schr�der, F.H., et al.. (2000). Prostate-specific antigen: A surrogate endpoint for screening new agents against prostate cancer?. The Prostate. 42(2). 107–115. 24 indexed citations
8.
Beemsterboer, Petra M. M., Harry J. de Koning, Erwin Birnie, P.J. van der Maas, & F.H. Schr�der. (1999). Advanced prostate cancer: Course, care, and cost implications. The Prostate. 40(2). 97–104. 26 indexed citations
9.
Beemsterboer, Petra M. M., Ries Kranse, Harry J. de Koning, J. Dik F. Habbema, & F.H. Schr�der. (1999). Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam). International Journal of Cancer. 84(4). 437–441. 73 indexed citations
10.
Hoedemaeker, Robert F., Ries Kranse, John Rietbergen, et al.. (1999). Evaluation of prostate needle biopsies in a population-based screening study. Cancer. 85(1). 145–152. 56 indexed citations
11.
Kooistra, A., J.C. Romijn, & F.H. Schr�der. (1997). Stromal inhibition of epithelial cell growth in the prostate; overview of an experimental study. Urological Research. 25(S2). S97–S105. 18 indexed citations
12.
Verkaik, Nicole S., F.H. Schr�der, & Johannes C. Romijn. (1997). Clinical usefulness of RT-PCR detection of hematogenous prostate cancer spread. Urological Research. 25(6). 373–384. 9 indexed citations
13.
Ackaert, Koen & F.H. Schr�der. (1989). Effects of extracorporeal shock wave lithotripsy (ESWL) on renal tissue. Urological Research. 17(1). 3–7. 55 indexed citations
14.
15.
Romijn, Johannes C., et al.. (1987). Prostatic epithelium inhibiting factor (PEIF): Organ specificity and production by prostatic fibroblasts. Urological Research. 15(3). 145–9. 20 indexed citations
16.
Hoekstra, J.W., et al.. (1983). A new method for permanent catheterisation in the dog. Urological Research. 11(4). 191–3. 1 indexed citations
17.
Kurth, K. H., et al.. (1983). Single-dose intravesical Epodyl after TUR of Ta TCC bladder carcinoma. World Journal of Urology. 1(2). 89–93. 16 indexed citations
18.
Melchior, H., et al.. (1977). Abstracts of the 3rd symposium on experimental urology, W�rzburg, April 1?3, 1976. Urological Research. 5(1). 6 indexed citations
19.
Okada, K & F.H. Schr�der. (1974). Human prostatic carcinoma in cell culture: Preliminary report on the development and characterization of an epithelial cell line (EB 33). Urological Research. 2(3). 111–21. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gustavo de la Roza Breakdown of academic impact, for papers by H.Ballentine Carter Breakdown of academic impact, for papers by Michael Froehner Breakdown of academic impact, for papers by Oliver W. Hakenberg Breakdown of academic impact, for papers by Sven Wenske Breakdown of academic impact, for papers by S Conquy Breakdown of academic impact, for papers by Abdel-Rahmène Azzouzi Breakdown of academic impact, for papers by Vito Mancini Breakdown of academic impact, for papers by J. Erik Busby Breakdown of academic impact, for papers by Noriaki Utsunomiya
Rankless by CCL
2026